Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
Xiaoqi LiDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaXin WangDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaBinyu WangFourth Affiliated Hospital of Harbin Medical UniversityWei-Qun ChiFourth Affiliated Hospital of Harbin Medical UniversityZhangyi LiDepartment of Biochemistry and Life Sciences, Faculty of Arts and Sciences, Queen's University, Kingston, Ontario, CanadaMin ZhangFourth Affiliated Hospital of Harbin Medical UniversityYifu ShenFourth Affiliated Hospital of Harbin Medical UniversityXu LiuFourth Affiliated Hospital of Harbin Medical UniversityYoumei LuDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaYu LiuDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: [email protected]
2022en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba